Revenue
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $43.3M | $36.5M | $36.6M | $13.1M |
| Gross profit | $9.3M | $9.6M | $8.0M | $3.4M |
| Gross margin | 21.40% | 26.20% | 21.75% | 25.67% |
| Research & development | $7.8M | $3.5M | $2.3M | $449,828 |
| Operating expenses | $16.1M | $6.5M | $5.0M | $1.5M |
| Operating income | −$6.8M | $3.1M | $3.0M | $1.8M |
| Operating margin | −15.77% | 8.43% | 8.15% | 14.02% |
| EBITDA | −$6.8M | $3.1M | $3.0M | $1.8M |
| EBITDA margin | −15.69% | 8.50% | 8.20% | 14.11% |
| Net income | −$5.7M | $3.1M | $2.8M | $1.6M |
| Net profit margin | −13.16% | 8.55% | 7.70% | 12.32% |
| Basic EPSper basic share | -$1.74 | $1.00 | $0.90 | $0.03 |
| Diluted EPSper diluted share | -$1.74 | $1.00 | $0.90 | $0.03 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
UBS Group AG | 10.28K |
Tower Research Capital LLC (TRC) | 298 |
ROYAL BANK OF CANADA | 19 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.